Tyson 2.0 Launch Exposes the 'White Label' Market and Social Equity Contradictions

CT CannaTimes - 5.14.2026

Connecticut consumers are being told that Mike Tyson’s cannabis brand is officially coming to the state through Rodeo Cannabis in Rocky Hill.

But despite the marketing push, no actual cannabis flower or high-THC products from Tyson’s out-of-state operations are entering Connecticut.

They legally cannot.

Under federal law and Connecticut cannabis regulations, adult-use cannabis products cannot cross state lines into Connecticut’s licensed market. That means the “Tyson 2.0” products launching here are being produced within Connecticut’s existing cannabis system and simply sold under Tyson’s branding.

In other words: this is white-label cannabis.

White labeling is common across multiple industries. One company produces a product while another company markets it under a different brand name, packaging, or celebrity partnership. In Connecticut cannabis, that often means the same limited group of cultivators and processors supplying products that later appear on dispensary shelves under multiple brand identities.

So while consumers may see “new” brands entering Connecticut, the underlying supply chain often remains the same.

The Tyson 2.0 launch highlights a larger issue many Connecticut cannabis consumers and advocates have raised for years: the state’s cannabis market often creates the appearance of variety and competition while remaining heavily controlled by a relatively small number of operators and business relationships.

Different packaging. Different logos. Same system.

The Hartford Courant article announcing the launch states that Rodeo Cannabis grows its products in Litchfield County. The article also notes that Tyson 2.0 products will initially launch exclusively through Rodeo’s Rocky Hill dispensary before expanding elsewhere.

This is not Connecticut suddenly gaining access to some entirely separate national cannabis supply chain. It is a branding partnership operating within Connecticut’s already existing market structure.

The situation becomes more controversial when looking at Rodeo Cannabis co-founder Arthur Linares.

Before entering the cannabis business, Linares was a Republican state senator who publicly opposed marijuana legalization efforts in Connecticut. During legislative debates years ago, Linares criticized legalization proposals and warned about the impacts of cannabis expansion.

Now, after legalization created a highly restricted and valuable licensing system, Linares is operating inside the legal cannabis industry and participating in celebrity-branded cannabis partnerships.

At the same time, Connecticut’s Social Equity Council has publicly praised Linares as an example of cannabis equity success.

In a 2025 press release, the Social Equity Council wrote that Linares was “demonstrating how established business leaders can turn opportunity into shared ownership and lasting impact.”

The release also quoted Linares saying:

“What’s so inspirational about this program is that it creates opportunities that can change lives.”

For many people who supported cannabis reform hoping it would create opportunities for legacy operators, small businesses, medical patients, and communities harmed by prohibition, this is where frustration with Connecticut’s system comes from.

Critics argue that Connecticut’s cannabis market increasingly rewards politically connected and well-capitalized business figures while many smaller operators remain locked out by high costs, licensing barriers, zoning restrictions, and limited cultivation opportunities.

That criticism becomes harder to ignore when one of the state’s celebrated “social equity” examples is a wealthy former anti-cannabis politician whose wife is Stamford Mayor Caroline Simmons.

The Tyson 2.0 rollout also raises a broader question: how much actual competition exists in Connecticut cannabis?

Consumers are constantly introduced to “new” products, “new” brands, and “exclusive launches,” but many of these products still originate from the same small circle of licensed cultivators, processors, and partner companies operating within Connecticut’s tightly controlled system.

To many consumers, it feels less like an open cannabis market and more like a branding carousel.

The issue is not whether Tyson 2.0 products are good or bad. The issue is whether Connecticut’s cannabis industry is genuinely expanding opportunity and competition, or simply repackaging the same limited supply chain under increasingly marketable names.

And for a state that repeatedly justified its cannabis laws using the language of equity, inclusion, and repairing harm from prohibition, many believe the current system looks far closer to corporate consolidation than cannabis justice.